Rheumatoid Arthritis

We have done extensive consulting work in the area of Rheumatoid Arthritis as well as in other inflammatory disease areas. Additional contents regarding our service offerings in this area will be coming soon so please check back later.

We have developed a RA clinical outcomes database which serves as a great enabling tool in our consulting projects as well as a stand-alone product for interested clients (please see product section for details on our database offerings). The objective of the database is to include all information on biologic DMARDs as well as synthetic DMARDs currently approved or in development. The indications are rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), juvenile rheumatoid arthritis (JRA), psoriatic arthritis (PsA), or psoriasis (PSO).

A total of 129 references were selected for inclusion in the database, representing clinical outcomes from 94 unique trials, 301 unique treatment arms and about 38,460 patients. Download a summary description for the RA database.